Jack Yongfeng Zhang

2019

In 2019, Jack Yongfeng Zhang earned a total compensation of $6M as Chief Executive Officer, President, Chief Scientific Officer and Director at Amphastar Pharmaceuticals, a 2% increase compared to previous year.

Compensation breakdown

Bonus$393,739
Non-Equity Incentive Plan$680,900
Option Awards$1,989,985
Salary$897,585
Stock Awards$1,990,018
Other$17,515
Total$5,969,742

Zhang received $2M in stock awards, accounting for 33% of the total pay in 2019.

Zhang also received $393.7K in bonus, $680.9K in non-equity incentive plan, $2M in option awards, $897.6K in salary and $17.5K in other compensation.

Rankings

In 2019, Jack Yongfeng Zhang's compensation ranked 1,724th out of 13,971 executives tracked by ExecPay. In other words, Zhang earned more than 87.7% of executives.

ClassificationRankingPercentile
All
1,724
out of 13,971
88th
Division
Manufacturing
616
out of 5,695
89th
Major group
Chemicals And Allied Products
185
out of 2,194
92nd
Industry group
Drugs
148
out of 1,880
92nd
Industry
Pharmaceutical Preparations
110
out of 1,392
92nd
Source: SEC filing on April 15, 2020.

Zhang's colleagues

We found four more compensation records of executives who worked with Jack Yongfeng Zhang at Amphastar Pharmaceuticals in 2019.

2019

Mary Luo

Amphastar Pharmaceuticals

Chief Operating Officer

2019

Jason Shandell

Amphastar Pharmaceuticals

General Counsel

2019

William Peters

Amphastar Pharmaceuticals

Chief Financial Officer

2019

Rong Zhou

Amphastar Pharmaceuticals

Executive Vice President of Production and President of Armstrong Pharmaceuticals, Inc

News

You may also like